A Multicenter, Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study of BB3 toReduce the Severity of Delayed Graft Function in Recipients of a Deceased Donor Kidney

Project: Research project

Project Details

Description

A Multicenter, Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study of BB3 to Reduce the Severity of Delayed Graft Function in Recipients of a Deceased Donor Kidney
StatusActive
Effective start/end date4/1/183/31/21

Funding

  • Angion Biomedica Corp.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.